BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND HLA-A, P01892, 3105, ENSG00000206503, P16188, P30447, P13746, P04439 AND Clinical Outcome
19 results:

  • 1. Adaptive and Innate Cytotoxic Effectors in Chronic Lymphocytic Leukaemia (CLL) Subjects with Stable Disease.
    Rubino V; Carriero F; Palatucci AT; Giovazzino A; Leone S; Nicolella V; CalabrĂ² M; Montanaro R; Brancaleone V; Pane F; Chiurazzi F; Ruggiero G; Terrazzano G
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298547
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Mechanisms of leukemia Immune Evasion and Their Role in Relapse After Haploidentical Hematopoietic Cell Transplantation.
    Rovatti PE; Gambacorta V; Lorentino F; Ciceri F; Vago L
    Front Immunol; 2020; 11():147. PubMed ID: 32158444
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Gene Map of the HLA Region, Graves' Disease and Hashimoto Thyroiditis, and Hematopoietic Stem Cell Transplantation.
    Sasazuki T; Inoko H; Morishima S; Morishima Y
    Adv Immunol; 2016; 129():175-249. PubMed ID: 26791860
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The impact of HLA and KIR ligand mismatching on unrelated allogeneic hematopoietic stem cell transplantation in Korean adult patients.
    Park H; Rho EY; In JW; Kim I; Yoon SS; Park S; Shin S; Park KU; Song EY
    Ann Lab Med; 2015 Jan; 35(1):111-7. PubMed ID: 25553290
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Scoring HLA class I mismatches by HistoCheck does not predict clinical outcome in unrelated hematopoietic stem cell transplantation.
    Spellman S; Klein J; Haagenson M; Askar M; Baxter-Lowe LA; He J; Hsu S; Blasczyk R; Hurley C
    Biol Blood Marrow Transplant; 2012 May; 18(5):739-46. PubMed ID: 21963622
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The effect of HLA disparity on clinical outcome after HLA-haploidentical blood and marrow transplantation.
    Huo MR; Xu LP; Li D; Liu DH; Liu KY; Chen H; Han W; Chen YH; Wang Y; Wang JZ; Zhang XH; Zhao XY; Huang XJ
    Clin Transplant; 2012; 26(2):284-91. PubMed ID: 21919963
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: a study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian Bone Marrow Donor Registry.
    Crocchiolo R; Ciceri F; Fleischhauer K; Oneto R; Bruno B; Pollichieni S; Sacchi N; Sormani MP; Fanin R; Bandini G; Bonifazi F; Bosi A; Rambaldi A; Alessandrino PE; Falda M; Bacigalupo A
    Bone Marrow Transplant; 2009 Nov; 44(9):571-7. PubMed ID: 19363528
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia.
    Arora M; Weisdorf DJ; Spellman SR; Haagenson MD; Klein JP; Hurley CK; Selby GB; Antin JH; Kernan NA; Kollman C; Nademanee A; McGlave P; Horowitz MM; Petersdorf EW
    J Clin Oncol; 2009 Apr; 27(10):1644-52. PubMed ID: 19224849
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. High avidity myeloid leukemia-associated antigen-specific CD8+ T cells preferentially reside in the bone marrow.
    Melenhorst JJ; Scheinberg P; Chattopadhyay PK; Gostick E; Ladell K; Roederer M; Hensel NF; Douek DC; Barrett AJ; Price DA
    Blood; 2009 Mar; 113(10):2238-44. PubMed ID: 18997173
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Impact of HLA class I and class II DNA high-resolution HLA typing on clinical outcome in adult unrelated stem cell transplantation after in vivo T-cell depletion with alemtuzumab.
    Perz JB; Szydlo R; Sergeant R; Sanz J; O'Shea D; Khan T; Davey N; Loaiza S; Davis J; Apperley JF; Olavarria E
    Transpl Immunol; 2007 Nov; 18(2):179-85. PubMed ID: 18005865
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Immunogenetic factors in donors and patients that affect the outcome of hematopoietic stem cell transplantation.
    Madrigal A; Shaw BE
    Blood Cells Mol Dis; 2008; 40(1):40-3. PubMed ID: 17964196
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Effect of hla-a2 allele disparity on clinical outcome in hematopoietic cell transplantation from unrelated donors.
    Morishima Y; Kawase T; Malkki M; Petersdorf EW;
    Tissue Antigens; 2007 Apr; 69 Suppl 1():31-5. PubMed ID: 17445159
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Effects of HLA allele and killer immunoglobulin-like receptor ligand matching on clinical outcome in leukemia patients undergoing transplantation with T-cell-replete marrow from an unrelated donor.
    Morishima Y; Yabe T; Matsuo K; Kashiwase K; Inoko H; Saji H; Yamamoto K; Maruya E; Akatsuka Y; Onizuka M; Sakamaki H; Sao H; Ogawa S; Kato S; Juji T; Sasazuki T; Kodera Y;
    Biol Blood Marrow Transplant; 2007 Mar; 13(3):315-28. PubMed ID: 17317585
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically hla-a, HLA-B, and HLA-DR matched unrelated donors.
    Morishima Y; Sasazuki T; Inoko H; Juji T; Akaza T; Yamamoto K; Ishikawa Y; Kato S; Sao H; Sakamaki H; Kawa K; Hamajima N; Asano S; Kodera Y
    Blood; 2002 Jun; 99(11):4200-6. PubMed ID: 12010826
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience.
    Petersdorf EW; Kollman C; Hurley CK; Dupont B; Nademanee A; Begovich AB; Weisdorf D; McGlave P
    Blood; 2001 Nov; 98(10):2922-9. PubMed ID: 11698272
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. HLA class I in acute promyelocytic leukemia (APL): possible correlation with clinical outcome.
    Bolognesi E; Cimino G; Diverio D; Rapanotti MC; D'Alfonso S; Fleischhauer K; Migliaretti G; Momigliano-Richiardi P
    Leukemia; 2000 Mar; 14(3):393-8. PubMed ID: 10720132
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. HLA-C and HLA-DQB1 compatibility in unrelated cord blood transplants.
    Elia L; Arcese W; Torello M; Iori AP; Guglielmi C; Perrone MP; Screnci M; Sprovieri T; Rapanotti MC; Cimino G
    Haematologica; 1999 Jun; 84(6):530-4. PubMed ID: 10366797
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program.
    Sasazuki T; Juji T; Morishima Y; Kinukawa N; Kashiwabara H; Inoko H; Yoshida T; Kimura A; Akaza T; Kamikawaji N; Kodera Y; Takaku F
    N Engl J Med; 1998 Oct; 339(17):1177-85. PubMed ID: 9780337
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. HLA matching in unrelated donor bone marrow transplantation.
    Charron DJ
    Curr Opin Hematol; 1996 Nov; 3(6):416-22. PubMed ID: 9372112
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.